# Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis

> **NCT05072938** · PHASE4 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 260 (actual)

## Conditions studied

- Gastritis

## Interventions

- **DRUG:** Mucotra SR Tablet 150mg
- **DRUG:** Axid Capsule 150mg

## Key facts

- **NCT ID:** NCT05072938
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-30
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05072938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05072938, "Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05072938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*